Abstract
The range of radiopharmaceuticals available for lymphoscintigraphy including radiocolloids, radiolabeled macromolecules and monoclonal antibodies are briefly discussed. The techniques used for tumour staging in internal mammary lymphoscintigraphy, iliopelvic lymphoscintigraphy, peripheral lymphoscintigraphy, localization of 'at risk' lymph nodes and lymphedema are also reviewed. (UK).
Kramer, E L
[1]
- Memorial Sloan-Kettering Cancer Center, New York, NY (USA)
Citation Formats
Kramer, E L.
Lymphoscintigraphy: radiopharmaceutical selection and methods.
United Kingdom: N. p.,
1990.
Web.
Kramer, E L.
Lymphoscintigraphy: radiopharmaceutical selection and methods.
United Kingdom.
Kramer, E L.
1990.
"Lymphoscintigraphy: radiopharmaceutical selection and methods."
United Kingdom.
@misc{etde_6604343,
title = {Lymphoscintigraphy: radiopharmaceutical selection and methods}
author = {Kramer, E L}
abstractNote = {The range of radiopharmaceuticals available for lymphoscintigraphy including radiocolloids, radiolabeled macromolecules and monoclonal antibodies are briefly discussed. The techniques used for tumour staging in internal mammary lymphoscintigraphy, iliopelvic lymphoscintigraphy, peripheral lymphoscintigraphy, localization of 'at risk' lymph nodes and lymphedema are also reviewed. (UK).}
journal = []
volume = {17:1}
place = {United Kingdom}
year = {1990}
month = {Jan}
}
title = {Lymphoscintigraphy: radiopharmaceutical selection and methods}
author = {Kramer, E L}
abstractNote = {The range of radiopharmaceuticals available for lymphoscintigraphy including radiocolloids, radiolabeled macromolecules and monoclonal antibodies are briefly discussed. The techniques used for tumour staging in internal mammary lymphoscintigraphy, iliopelvic lymphoscintigraphy, peripheral lymphoscintigraphy, localization of 'at risk' lymph nodes and lymphedema are also reviewed. (UK).}
journal = []
volume = {17:1}
place = {United Kingdom}
year = {1990}
month = {Jan}
}